LEO Pharma to Showcase Two Dozen Data Presentations at 27th Annual European Academy of Dermatology and Venerology Congress in Paris
BALLERUP, Denmark--(BUSINESS WIRE)--Sep 12, 2018--LEO Pharma A/S, a global leader in medical dermatology, today announced that 24 key data abstracts will be presented during the 27 th annual European Academy of Dermatology and Venerology (EADV) Congress in Paris this week.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180911005831/en/
“Atopic dermatitis and psoriasis are two of the most common yet debilitating skin diseases that can have a profound impact on the quality of lives of people around the world, so there is still a huge unmet need for more and better treatment options,” said Kim Domela Kjøller, EVP of Global R&D at LEO Pharma A/S. “We’re excited about the scientific data being presented this week at the EADV as we continue our mission to develop new, innovative therapies to help patients achieve healthy skin.”
Please see the full press release text attached.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180911005831/en/
CONTACT: Global Media Contacts
LEO Pharma A/S
Tel. +45 3140 6180
KEYWORD: EUROPE DENMARK
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS PHARMACEUTICAL OTHER HEALTH
SOURCE: LEO Pharma A/S
Copyright Business Wire 2018.
PUB: 09/12/2018 02:00 AM/DISC: 09/12/2018 02:01 AM